Correction to: Population pharmacokinetics of trastuzumab emtansine in previously treated patients with HER2-positive advanced gastric cancer (AGC)

Cancer Chemother Pharmacol. 2018 Feb;81(2):421-422. doi: 10.1007/s00280-017-3488-1.

Authors

Shang-Chiung Chen¹, Matts Kagedal², Yuying Gao³, Bei Wang², Marie-Laurence Harle-Yge⁴, Sandhya Girish², Jin Jin², Chunze Li²

Affiliations

¹ Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. chen.shangchiung@gene.com.
² Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
³ Certara USA, 100 Overlook Center #101, Princeton, NJ, 08540, USA.
⁴ F. Hoffmann-La Roche Ltd., 4070, Basel, Switzerland.

PMID: 29189914
DOI: 10.1007/s00280-017-3488-1

Abstract

The online version of the original article can be.

Publication types

Published Erratum